Companies: 10,795·Total market cap: $144.5T
Eli Lilly and Company

Eli Lilly and Company

LLY.TOTSXHealthcare● Active
$40.68
+$0.22(+0.54%)
Market Cap$1.40T
P/E Ratio—
52W High$41.89
52W Low$30.67
Overview

Eli Lilly and Company (LLY.TO) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

LLY.TO · earnings · updated Jun 8, 2026

No earnings history available.

Next Earnings Date

Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
No earnings history available.
No analyst estimates available for LLY.TO.

About Earnings & Data Methodology

Data source: Financial Modeling Prep (FMP)  |  Updated: Hourly  |  Surprise%: (Actual − Estimate) / |Estimate| × 100  |  Fiscal year: LLY.TO ends December

Eli Lilly and Company (LLY.TO) reports earnings quarterly as a TSX-listed Medical - Pharmaceuticals company. The next LLY.TO earnings date is expected around September 1, 2026.

Each quarter, investors track LLY.TO earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. LLY.TO revenue tab →

Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
LLY.TO's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
RevenuePrice historyFinancial statementsForecastDividendsMarket cap

Frequently asked questions

LLY.TO earnings · 3 questions

Eli Lilly and Company's next earnings report is expected around September 1, 2026. LLY.TO typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; LLY.TO historically reports after market close (AMC).

LLY.TO earnings datewhen is LLY.TO earningsLLY.TO next earnings datewhen does LLY.TO report earningsLLY.TO earnings calendar

▸ Source: FMP · Eli Lilly and Company SEC filings · US GAAP · Eli Lilly and Company SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026